Fetal bovine serum (FBS) refers to the serum derived from fetal blood collected from cattle during slaughter. It finds wide application as a supplement in cell and tissue culture media due to the presence of growth factors necessary for cell growth. The demand for FBS has witnessed significant growth over the years owing to its indispensable usage in biopharmaceutical research and manufacturing processes. It supports the growth of various cell lines and enables the isolation, expansion, and propagation of cells. FBS also enhances the viability and longevity of cells outside their natural environment.

The Global Fetal Bovine Serum Market is estimated to be valued at US$ 1.86 Bn in 2024 and is expected to exhibit a CAGR of 13. % over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Fetal Bovine Serum Market are Merck KGaA, Thermo Fisher Scientific Inc., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc., Rocky Mountain Biologicals, Cytiva, Sartorius AG, and SeraCare Life Sciences. These players are focusing on expanding their production capacities and geographical footprint to cater to the growing demand.

The key opportunities in the Fetal Bovine Serum Market Demand include rising investment by biopharma companies in R&D, growing demand for monoclonal antibodies and therapeutic proteins, and increasing prevalence of chronic diseases globally. The market players are eyeing opportunities in emerging economies in Asia Pacific and Latin America owing to increasing biologics production in these regions.

Major players are undertaking strategic initiatives such as mergers, acquisitions, and expansion of production facilities across regions to strengthen their global presence. For instance, in 2021, Merck KGaA acquired ChromoTek to augment its portfolio of reagents for cell and gene therapy applications.

Market drivers: The primary driver for the fetal bovine serum market is the growing biologics industry. Biologics such as vaccines and monoclonal antibodies are in high demand for treating various diseases. Since FBS is essential for cell culture media used in biologics production, its demand is surging with the expansion of this industry.

Market restraints: One of the major challenges for the market players is overcoming ethical concerns associated with the use of fetal calf serum. Many organizations promote the use of alternative cell culture media replacing FBS. Stringent regulations pertaining to the manufacture and import of FBS products also act as a restraint for market players.

Segment Analysis
Fetal Bovine Serum market is segmented based on its applications in Biopharmaceuticals & Pharmaceuticals, Cell Culture, Human & Animal vaccine production and Diagnostics. The biopharmaceuticals & pharmaceuticals segment is currently dominating the market owing to high demand for fetal bovine serum in production of monoclonal antibodies, therapeutics, and other biologics. It holds around 35-40% share of the total market. Within cell culture application fetal bovine serum is used in culturing many different type of cells including stem cells, primary cells and immortalized cell lines. This segment holds second largest share and is also witnessing impressive growth.

Global Analysis
In terms of regions, North America currently commands the largest market share primarily due to robust research activities in drug discovery and biopharmaceutical industry. The region accounts for approximately 40% revenue share. Presence of key players and increasing production of biologics and cell therapy products is fueling the North America fetal bovine serum market. Asia Pacific region is projected to witness highest CAGR during forecast period owing to increasing healthcare expenditures, rising stem cell research, growing biotech industry and massive investments by governments in life science research.

Get More Insights on- Fetal Bovine Serum Market

About Author:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )